Checkpoint Capital L.p.

Investment Portfolio & 13F Holdings Analysis

About

CIK: 0001977548

Type: FundHoldings: 14Value: $182.3MLatest: 2025Q1

Checkpoint Capital L.P. is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 14 holdings worth $0.2 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

AI_NATIVE detailed information: This accession holds the following tickers:[
  "RVMD",
  "ARGX",
  "TCRX",
  "STOK",
  "KYMR",
  "SEPN",
  "RAPT",
  "PTGX",
  "RYTM",
  "SLNO",
  "CDTX",
  "IMCR",
  "CORT",
  "IRON"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 14
Total Value: 182265533
Accession Number: 0001977548-25-000005
Form Type: 13F-HR
CIK: checkpoint-capital-lp
Manager Name: Checkpoint-Capital-Lp

Data Enrichment

100% identified

14 identified0 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

14 positions • $182.3M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Sort by:

ARGENX SE

ARGX|04016X101

Shares:115.0K

Value:$68.1M

% of Portfolio:37.3% ($68.1M/$182.3M)

RHYTHM PHARMACEUTICALS, INC.

RYTM|76243J105

Shares:907.2K

Value:$48.1M

% of Portfolio:26.4% ($48.1M/$182.3M)

Revolution Medicines, Inc.

RVMD|76155X100

Shares:392.0K

Value:$13.9M

% of Portfolio:7.6% ($13.9M/$182.3M)

SOLENO THERAPEUTICS INC

SLNO|834203309

Shares:172.9K

Value:$12.4M

% of Portfolio:6.8% ($12.4M/$182.3M)

Disc Medicine, Inc.

IRON|254604101

Shares:243.3K

Value:$12.1M

% of Portfolio:6.6% ($12.1M/$182.3M)

Protagonist Therapeutics, Inc

PTGX|74366E102

Shares:175.2K

Value:$8.5M

% of Portfolio:4.6% ($8.5M/$182.3M)

Stoke Therapeutics, Inc.

STOK|86150R107

Shares:730.7K

Value:$4.9M

% of Portfolio:2.7% ($4.9M/$182.3M)

Septerna, Inc.

SEPN|81734D104

Shares:824.9K

Value:$4.8M

% of Portfolio:2.6% ($4.8M/$182.3M)

Kymera Therapeutics, Inc.

KYMR|501575104

Shares:136.6K

Value:$3.7M

% of Portfolio:2.1% ($3.7M/$182.3M)

TScan Therapeutics, Inc.

TCRX|89854M101

Shares:2.0M

Value:$2.8M

% of Portfolio:1.5% ($2.8M/$182.3M)

Cidara Therapeutics, Inc.

CDTX|171757206

Shares:104.4K

Value:$2.2M

% of Portfolio:1.2% ($2.2M/$182.3M)

CORCEPT THERAPEUTICS INC

CORT|218352102

Shares:5.0K

Value:$571.1K

% of Portfolio:0.3% ($571.1K/$182.3M)

Immunocore Holdings plc

IMCR|45258D105

Shares:9.0K

Value:$267.4K

% of Portfolio:0.1% ($267.4K/$182.3M)

RAPT Therapeutics, Inc.

RAPT|75382E109

Shares:109.8K

Value:$134.0K

% of Portfolio:0.1% ($134.0K/$182.3M)

Instrument	Shares		Other Manager	Value	% of Portfolio
ARGENX SE(ARGXcusip04016X101)	115.0K	QoQ +24.32% (+22.5K) YoY +40.24% (+33.0K)	All Managers (Combined)	$68.1M	37.3% ($68.1M/$182.3M)	QoQ +19.64% (+$11.2M) YoY +110.82% (+$35.8M)
RHYTHM PHARMACEUTICALS, INC.(RYTMcusip76243J105)	907.2K	QoQ +24.62% (+179.3K) YoY +9.90% (+81.7K)	All Managers (Combined)	$48.1M	26.4% ($48.1M/$182.3M)	QoQ +17.92% (+$7.3M) YoY +34.35% (+$12.3M)
Revolution Medicines, Inc.(RVMDcusip76155X100)	392.0K	QoQ +86.67% (+182.0K) YoY NEW(+392.0K)	All Managers (Combined)	$13.9M	7.6% ($13.9M/$182.3M)	QoQ +50.90% (+$4.7M) YoY NEW(+$13.9M)
SOLENO THERAPEUTICS INC(SLNOcusip834203309)	172.9K	QoQ +146.90% (+102.9K) YoY NEW(+172.9K)	All Managers (Combined)	$12.4M	6.8% ($12.4M/$182.3M)	QoQ +292.47% (+$9.2M) YoY NEW(+$12.4M)
Disc Medicine, Inc.(IRONcusip254604101)	243.3K	QoQ +31.51% (+58.3K) YoY NEW(+243.3K)	All Managers (Combined)	$12.1M	6.6% ($12.1M/$182.3M)	QoQ +2.97% (+$349.0K) YoY NEW(+$12.1M)
Protagonist Therapeutics, Inc(PTGXcusip74366E102)	175.2K	QoQ NEW(+175.2K) YoY -37.50% (-105.1K)	All Managers (Combined)	$8.5M	4.6% ($8.5M/$182.3M)	QoQ NEW(+$8.5M) YoY +4.47% (-$362.8K)
Stoke Therapeutics, Inc.(STOKcusip86150R107)	730.7K	QoQ +139.27% (+425.3K) YoY NEW(+730.7K)	All Managers (Combined)	$4.9M	2.7% ($4.9M/$182.3M)	QoQ +44.25% (+$1.5M) YoY NEW(+$4.9M)
Septerna, Inc.(SEPNcusip81734D104)	824.9K	QoQ NEW(+824.9K) YoY NEW(+824.9K)	All Managers (Combined)	$4.8M	2.6% ($4.8M/$182.3M)	QoQ NEW(+$4.8M) YoY NEW(+$4.8M)
Kymera Therapeutics, Inc.(KYMRcusip501575104)	136.6K	QoQ +76.18% (+59.1K) YoY NEW(+136.6K)	All Managers (Combined)	$3.7M	2.1% ($3.7M/$182.3M)	QoQ +19.86% (+$619.6K) YoY NEW(+$3.7M)
TScan Therapeutics, Inc.(TCRXcusip89854M101)	2.0M	QoQ +14.90% (-261.7K) YoY NEW(+2.0M)	All Managers (Combined)	$2.8M	1.5% ($2.8M/$182.3M)	QoQ -47.84% (-$2.6M) YoY NEW(+$2.8M)
Cidara Therapeutics, Inc.(CDTXcusip171757206)	104.4K	QoQ -47.00% (-92.6K) YoY NEW(+104.4K)	All Managers (Combined)	$2.2M	1.2% ($2.2M/$182.3M)	QoQ -56.03% (-$2.9M) YoY NEW(+$2.2M)
CORCEPT THERAPEUTICS INC(CORTcusip218352102)	5.0K	QoQ NEW(+5.0K) YoY -98.17% (-268.8K)	All Managers (Combined)	$571.1K	0.3% ($571.1K/$182.3M)	QoQ NEW(+$571.1K) YoY -91.71% (-$6.3M)
Immunocore Holdings plc(IMCRcusip45258D105)	9.0K	QoQ NEW(+9.0K) YoY NEW(+9.0K)	All Managers (Combined)	$267.4K	0.1% ($267.4K/$182.3M)	QoQ NEW(+$267.4K) YoY NEW(+$267.4K)
RAPT Therapeutics, Inc.(RAPTcusip75382E109)	109.8K	QoQ NEW(+109.8K) YoY NEW(+109.8K)	All Managers (Combined)	$134.0K	0.1% ($134.0K/$182.3M)	QoQ NEW(+$134.0K) YoY NEW(+$134.0K)